top of page


Polyclinic HELENAMED International
Study:
PROSPECTIVE RANDOMIZED DOUBLE-BLIND CLINICAL TRIAL ON CANCER IMMUNOTHERAPY
​
Principal Investigator
Gaston BOMA, MD, MPH
Consultant Epidemiologist
Pharmacovigilance Expert
Certified Physician in USA, Nigeria and Cameroon
bottom of page